Santhera Pharmaceuticals Holding AG
SIX: SANN.SW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Swiss Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dario Eklund
- Employees
- 78
- Headquarters
- Pratteln, Switzerland
- IPO year
- 2006
- Market cap
- CHF 243.4M
- Website
- https://www.santhera.com
Loading SANN…
Loading profile data…Frequently asked questions about SANN
What does Santhera Pharmaceuticals Holding AG (SANN.SW) do?
Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes vamorolone, which is being developed as...
Where does SANN.SW trade?
Santhera Pharmaceuticals Holding AG (SANN.SW) trades on the Swiss Exchange.
What sector is SANN.SW in?
Santhera Pharmaceuticals Holding AG (SANN.SW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Santhera Pharmaceuticals Holding AG?
Dario Eklund is the chief executive officer of Santhera Pharmaceuticals Holding AG (SANN.SW).
Where is Santhera Pharmaceuticals Holding AG headquartered?
Santhera Pharmaceuticals Holding AG is headquartered in Switzerland.
Does SANN.SW pay a dividend?
Santhera Pharmaceuticals Holding AG (SANN.SW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SANN.SW go public?
Santhera Pharmaceuticals Holding AG (SANN.SW) completed its initial public offering in 2006.